Story · Longevity & Aging
18 Years of ITP Data: Excluding This Control Cohort Turns Intermittent Rapamycin From Lifespan Extension to a Trend Toward Reduction
1 outlet · first reported by Rapamycin News 9d ago
Coverage, in order
-
9d ago18 Years of ITP Data: Excluding This Control Cohort Turns Intermittent Rapamycin From Lifespan Extension to a Trend Toward Reduction
Rapamycin’s status in the longevity field hardly needs elaborate setup. From the NIA Interventions Testing Program (ITP) first reporting mouse lifespan extension in 2006, to Harrison’s 2009 paper that electrified the field by showing benefit even when started at 20 months of age, to the 2025 PEARL…
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.